RxSight (RXST) EBT Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.78% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 74.66% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.02% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 54.33% |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn | -94.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.30% |
| Dec 31, 2025 | -142.58% |
| Sep 30, 2025 | -55.04% |
| Jun 30, 2025 | -93.86% |
| Mar 31, 2025 | 10.11% |
| Dec 31, 2024 | -45.48% |
| Sep 30, 2024 | 49.00% |
| Jun 30, 2024 | 56.00% |
| Mar 31, 2024 | 31.19% |
| Dec 31, 2023 | -22.97% |
| Sep 30, 2023 | 26.25% |
| Jun 30, 2023 | 17.65% |
| Mar 31, 2023 | 24.90% |
| Dec 31, 2022 | 424.81% |
| Sep 30, 2022 | -32.67% |
| Jun 30, 2022 | -24.18% |
| Mar 31, 2022 | -158.78% |
| Dec 31, 2021 | -160.00% |
| Sep 30, 2021 | -141.33% |
| Jun 30, 2021 | -4.92% |